ARCHIVES

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Generic Paclitaxel Approval Withstands Court Challenge.

May 4, 2001

Risk of Lymphoma Increases with Hepatitis C Virus Infection

May 25, 2007

NIH Entertainment: Wild Type Wins First, The Directors Second, In Battle of Bands

October 15, 1999

In Brief: Three More Comprehensive Centers May Be Names; Hawaii, Cleveland, Ohio State Lead List of 10

May 9, 1975

Older Patients Tolerate Chemo, Decline Due To Severe Toxicity

February 28, 2003

CCOPs, Research Base Awards Are Listed

November 19, 1993